Stay Up
to Date
Stay Up
to Date
Breaking News,
Updates, & More
Breaking News,
Updates, & More
Click Here to
Subscribe
Click Here to
Subscribe

Daratumumab: What Patients Want to Know

Leslie Lauersdorf, ARNP
Leslie Lauersdorf addresses the different questions her patients ask her when they begin daratumumab therapy.
Related Items
What is Minimal Residual Disease (MRD) Negativity?
Leslie Lauersdorf, ARNP
Videos published on December 6, 2019 in ASH 2019 MM, Multiple Myeloma, Video
Multiple Myeloma as a Chronic Disease
Leslie Lauersdorf, ARNP
Videos published on December 6, 2019 in ASH 2019 MM, Multiple Myeloma, Video
Triplets versus Quads
Leslie Lauersdorf, ARNP
Videos published on December 6, 2019 in ASH 2019 MM, Multiple Myeloma, Video
CAR T-Cell Data in Multiple Myeloma
Leslie Lauersdorf, ARNP
Videos published on December 6, 2019 in ASH 2019 MM, Multiple Myeloma, Video
Latest Developments in Multiple Myeloma
Leslie Lauersdorf, ARNP
Videos published on December 6, 2019 in ASH 2019 MM, Multiple Myeloma, Video
Sexual Dysfunction After Cancer: Why Aren’t We Talking About It?
Meg Barbor, MPH
TON - July 2018, Vol 11, No 3 published on July 25, 2018 in Conference Correspondent, ONS
The Importance of Compassion: Perspective From a Lifelong Patient
Meg Barbor, MPH
TON - July 2018, Vol 11, No 3 published on July 25, 2018 in Conference Correspondent, ONS
Using a Team Approach to Tackle Opioid Abuse in Patients with Cancer
Meg Barbor, MPH
TON - July 2018, Vol 11, No 3 published on July 25, 2018 in Conference Correspondent, ONS
Addressing the Second Victim Phenomenon
Charles Bankhead
TON - July 2018, Vol 11, No 3 published on July 25, 2018 in Conference Correspondent, ONS
Humanizing Cancer Care: The Patient Perspective
Gail Thompson
TON - March 2018, Vol 11, No 1 published on March 9, 2018 in Conference Correspondent, ACCC
Last modified: April 27, 2020